China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
August 24, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Y-3, a Class 1 Innovative Drug injection, is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic...
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
July 31, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, July 31, 2023 (GLOBE NEWSWIRE) -- Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and...
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global
June 29, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 29, 2023 (GLOBE NEWSWIRE) -- CMS was included into the first “Sustainability Yearbook (China)” published by S&P Global. Nearly 1600 Chinese companies were included in the...
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
June 12, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, June 12, 2023 (GLOBE NEWSWIRE) -- CMS is pleased to announce the NDA of the first Diazepam Nasal Spray has been approved for marketing in China. The Product can meet current...
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
May 30, 2023 10:30 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, May 30, 2023 (GLOBE NEWSWIRE) -- CMS is pleased to announce the NDA of Tildrakizumab Injection under the brand name of ILUMETRI, a monoclonal antibody specifically targeting the p19...
NOTICE TO DISREGARD -- China Medical System Holdings Ltd.
December 21, 2022 06:08 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, Dec. 21, 2022 (GLOBE NEWSWIRE) -- We are advised by China Medical System Holdings Ltd. that journalists and other readers should disregard the news release, "CMS (867.HK) Joins Hand...